InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Verwiel Frank, 董事. Officer active across 1 company, notably Intellia Therapeutics, Inc.. In total, 6 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €35k. History available since 23 June 2021. The latest transaction was filed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Verwiel Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
8,000 股0Common StockSEC:0000950170-25-086287:0
1,505 股@ US$25.00100.0% 占其流量Common StockSEC:0000950170-24-075718:0
7,737 股0Common StockSEC:0000950170-24-073704:0
4,425 股0Common StockSEC:0001209191-23-037898:0
5,197 股0Common StockSEC:0001209191-22-037604:0
2,094 股0Common StockSEC:0001209191-21-043385:0
6 条申报中的 6 条
About Verwiel Frank
Frank Verwiel is a Board Member at Intellia Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.
